Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 82.40
+0.25 (0.30%)
Oct 7, 2026, 3:51 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 13.81 billion as of October 7, 2026. That makes Vigonvita Life Sciences the world's 7,372nd most valuable company and 368th in Hong Kong.
Market Cap
13.81B
Enterprise Value
14.32B
Revenue
250.82M
Global Rank
Country Rank
#368 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has increased from 13.74B to 13.81B, an increase of 0.49%. That is a compound annual growth rate of 0.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 13.81B | 0.67% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 322.67B |
| WuXi Biologics | 237.61B |
| Hansoh Pharmaceutical Group Company | 209.77B |
| Innovent Biologics | 169.39B |
| The United Laboratories International Holdings | 14.97B |
| Shandong Weigao Group Medical Polymer Company | 14.56B |
| Angelalign Technology | 14.32B |
| Fujian Haixi Pharmaceuticals | 13.22B |